DarioHealth

New York, United States Founded: 2011 • Age: 15 yrs
Chronic conditions are managed via a personalized digital platform.
Annual revenue $27.0M Latest available
Total funding $6.0M 27 rounds
Employees 202 Tracked headcount
Investors 6 Known backers
Products 3 Services tracked
Competitors 8 Brand Intelligence

About DarioHealth

DarioHealth is a company based in New York (United States) founded in 2011. DarioHealth has raised $6.01 million across 27 funding rounds from investors including Driehaus, Perceptive Advisors and Manchester Capital Management. The company has 202 employees as of December 31, 2024. DarioHealth has completed 4 acquisitions, including PhysiMax, Twill and Upright Pose. DarioHealth offers products and services including Cardiometabolic Solution, Musculoskeletal Solution, and Behavioral Health Solution. DarioHealth operates in a competitive market with competitors including Welldoc, Wellthy Therapeutics, Liva Healthcare, Pear Therapeutics and Spiras Health, among others.

  • Headquarter New York, United States
  • Employees 202 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Dariohealth Corp.
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $27.04 M (USD)
    32.86
    as on Dec 31, 2024
  • Net Profit
    -$30.09 M (USD)
    45.15
    as on Dec 31, 2024
  • EBITDA
    -$48.68 M (USD)
    4.24
    as on Dec 31, 2024
  • Total Equity Funding
    $6.01 M (USD)

    in 27 rounds

  • Latest Funding Round
    $17.5 M (USD), Post-IPO

    Sep 22, 2025

  • Investors
    Driehaus

    & 5 more

  • Employee Count
    202

    as on Dec 31, 2024

  • Investments & Acquisitions
    PhysiMax

    & 3 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of DarioHealth

DarioHealth is a publicly listed company on the NASDAQ with ticker symbol DRIO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: DRIO · Sector: Health technology · USA

Products & Services of DarioHealth

DarioHealth offers a comprehensive portfolio of products and services, including Cardiometabolic Solution, Musculoskeletal Solution, and Behavioral Health Solution.

Product name locked
Category locked
Primary

Manages diabetes, hypertension, and weight through personalized digital tools.

Product name locked
Category locked
Locked

Improves strength, mobility, and reduces pain via guided exercises.

Product name locked
Category locked
Locked

Addresses anxiety, depression, and stress with evidence-based support.

People of DarioHealth

Headcount 50-200
Employee Profiles 44
Board Members and Advisors 11
Employee Profiles
People
Galya Gorodinksy
SVP, R&D & Delivery Solutions
People
Brian Harrigan
SVP of Employer Sales
People
Dror Bacher
COO
People
Eyal Rivlin
SVP, Marketing & Business Operations

Unlock access to complete

Board Members and Advisors
people
Eric Milledge
Chairman, SAB
people
David A. Horwitz
Scientific Advisor
people
Dennis Matheis
Board Member
people
Allen Kamer
Advisor

Unlock access to complete

Funding Insights of DarioHealth

DarioHealth has successfully raised a total of $6.01M across 27 strategic funding rounds. The most recent funding activity was a Post-IPO round of $17.5 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in DarioHealth

DarioHealth has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Driehaus, Perceptive Advisors and Manchester Capital Management.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Health-tech companies are targeted for venture capital investments.
Locked Locked Locked
-
Locked Locked Locked
Seed & early stage Digital Health focused VC firm funding companies in Israel
Locked Locked Locked
Premium access

Investor details for DarioHealth

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by DarioHealth

DarioHealth has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include PhysiMax, Twill and Upright Pose.

Investments
Premium access

Investment portfolio details for DarioHealth

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Evidence-based digital therapeutics and wellness apps for healthcare are provided.
Locked Locked 2017 Locked
AI and SaaS-based mental health management software for employees and individuals
Locked Locked 2014 Locked
Cloud-based sports analytics
Locked Locked 2012 Locked
Premium access

Complete acquisition details for DarioHealth

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - DarioHealth

Premium access

Detailed financials for DarioHealth

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Dariohealth Comparisons

DarioHealth Primary company
Description
Chronic conditions are managed via a personalized digital pl...
Location
New York, United States
Founded Year
2011
Annual Revenue
$27.04 M (USD)
Net Profit
-$30.09 M (USD)
EBITDA
-$48.68 M (USD)
Employees
202
As of 2024
Premium access

Peer comparison for DarioHealth

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of DarioHealth

DarioHealth operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Welldoc, Wellthy Therapeutics, Liva Healthcare, Pear Therapeutics and Spiras Health, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Mobile health products for chronic disease management are offered.
Locked Locked Locked
Health monitoring app is provided for chronic patients and providers.
Locked Locked Locked
Chronic care management solutions are provided for patients and professionals.
Locked Locked Locked
Pear Therapeutics provides cloud-based digital solutions for managing chronic health conditions effectively.
Locked Locked Locked
Asthma and COPD symptoms are managed through clinical services.
Premium access

Detailed competitors of DarioHealth

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Dariohealth

Premium access

Complete news archive for DarioHealth

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about DarioHealth

DarioHealth was founded in 2011.

DarioHealth is headquartered in New York, United States. It is registered at New York, New York, United States.

Erez Raphael is the current CEO of DarioHealth.

DarioHealth is a funded company, having raised a total of $6.01M across 27 funding rounds to date.

As of Dec 31, 2024, the latest employee count at DarioHealth is 202.

Annual revenue of DarioHealth is $27.04M as on Dec 31, 2024.

Founded in 2011 and headquartered in New York, United States, DarioHealth operates in the health technology sector. A mobile app is provided for tracking blood sugar levels, monitoring carbohydrate intake, and identifying health trends. Personalized coaching, behavioral insights, and AI algorithms are integrated to support routine management of chronic conditions like diabetes. Services are delivered digitally to users across various regions.

DarioHealth's top competitors include Welldoc, Wellthy Therapeutics and Ciba Health.

DarioHealth offers Cardiometabolic Solution, Musculoskeletal Solution, and Behavioral Health Solution.

Yes, DarioHealth is publicly traded on NASDAQ under the ticker symbol DRIO.

DarioHealth has made 4 acquisitions, including PhysiMax, Twill, and Upright Pose.

DarioHealth has 6 investors. Key investors include Driehaus, Perceptive Advisors, Manchester Capital Management, Nantahala Capital Management, and Soleus Capital.

The ticker symbol of DarioHealth is DRIO on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available